Major capsid protein L1
From Proteopedia
(18 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load='2R5H' size='340' side='right' caption='The L1 major capsid protein comprises the majority of Gardasil 9 | + | <StructureSection load='2R5H' size='340' side='right' caption='The L1 major capsid protein comprises the majority of Gardasil 9 (PDB code [[2r5h]])'> |
== Introduction== | == Introduction== | ||
- | Gardasil 9 is a recombinant vaccine for the human papillomavirus and protects from the 9 most common forms that are known to cause the majority of HPV-related diseases and cancer. These types are 6, 11, 16, 18, 31, 33, 45, 52, and 58. HPVs are the causative agents of human neoplasia such as warts and cancers <ref name="types">PMID: 27040313</ref>. The HPV vaccine is recommended for children ages 11 to 12 and is intended for females ages 9-25 and protects against cervical cancer, vulvar and vaginal cancer, anal cancer, and genital warts. The vaccine is also intended for males ages 9-26 and protects against anal cancer and genital warts <ref>https://www.gardasil9.com</ref>. Gardasil vaccine is made up of proteins that resemble the ones on the outside of an actual human papillomavirus <ref name="aus">http://www.hpvvaccine.org.au/the-hpv-vaccine/how-does-it-work.aspx</ref>.The main ingredient in Gardasil 9 is the<scene name='74/746002/L1_pentamer_structure/2'> L1 major capsid protein</scene> <ref name="L1">https://www.medicines.org.uk/emc/medicine/19016</ref>. | + | The '''major capsid protein L1''' (MCP) of papilloma virus is able to self-assemble into virus-like particles. The virus-like particles are potent immunogens and are a basis of effective vaccines which offer protection against the cancer-causing papilloma virus<ref> name="mcp>PMID:23800545</ref>. |
+ | |||
+ | '''Gardasil''' 9 is a recombinant vaccine for the human papillomavirus (HPV) and protects from the 9 most common forms that are known to cause the majority of HPV-related diseases and cancer. These types are 6, 11, 16, 18, 31, 33, 45, 52, and 58. HPVs are the causative agents of human neoplasia such as warts and cancers <ref name="types">PMID: 27040313</ref>. The HPV vaccine is recommended for children ages 11 to 12 and is intended for females ages 9-25 and protects against cervical cancer, vulvar and vaginal cancer, anal cancer, and genital warts. The vaccine is also intended for males ages 9-26 and protects against anal cancer and genital warts <ref>https://www.gardasil9.com</ref>. Gardasil vaccine is made up of proteins that resemble the ones on the outside of an actual human papillomavirus <ref name="aus">http://www.hpvvaccine.org.au/the-hpv-vaccine/how-does-it-work.aspx</ref>.The main ingredient in Gardasil 9 is the<scene name='74/746002/L1_pentamer_structure/2'> L1 major capsid protein</scene> <ref name="L1">https://www.medicines.org.uk/emc/medicine/19016</ref>. | ||
== Function == | == Function == | ||
- | Gardasil mimics the <scene name='74/746002/Hpv_monomer_16/1'>HPV virus</scene>, but it does not contain any viral DNA which removes any chance of infection of the HPV virus. This vaccine allows the body to create antibodies against HPV in order to be able to remove the virus if it is introduced in the body. Since the L1 protein is the main structural component of HPV and Gardasil, Gardasil can use this protein to remove HPV from the infected cells <ref name="aus" />. The antibodies provided by Gardasil prevent HPV infection by keeping the virus from entering the epithelial cells of the genitals. However, the antibodies created do not last forever, so the gardasil vaccine will need to be followed up with booster shots<ref> | + | Gardasil mimics the <scene name='74/746002/Hpv_monomer_16/1'>HPV virus</scene>, but it does not contain any viral DNA, which removes any chance of infection of the HPV virus. This vaccine allows the body to create antibodies against HPV in order to be able to remove the virus if it is introduced in the body. Since the L1 protein is the main structural component of HPV and Gardasil, Gardasil can use this protein to remove HPV from the infected cells <ref name="aus" />. The antibodies provided by Gardasil prevent HPV infection by keeping the virus from entering the epithelial cells of the genitals. However, the antibodies created do not last forever, so the gardasil vaccine will need to be followed up with booster shots<ref>PMID:23805398</ref>. Since Gardasil is a relatively recent developed vaccine, many specifics are still not known about how it functions. “The exact role of various immune mechanisms in the protective efficacy of the HPV L1 VLP vaccine remains to be determined <ref>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000703/WC500021140.pdf</ref>.” |
== Structural Highlights== | == Structural Highlights== | ||
- | The main ingredient in Gardasil 9 is L1 Major Capsid Protein<ref name="L1"/>. L1 Major Capsid Protein has 72 pentamers of major capsid proteins that are linked together by <scene name='74/746002/ | + | The main ingredient in Gardasil 9 is L1 Major Capsid Protein<ref name="L1"/>. L1 Major Capsid Protein has 72 pentamers of major capsid proteins that are linked together by <scene name='74/746002/L1_disulfide_bonds_final/1'>disulfide bonds</scene>, indicated in red on the monomer, that creates an icosahedral capsid with a T=7 symmetry, which is a spherical protein <ref>PMID:12663788</ref>. The disulfide bonds are formed to increase the stability of the pentamers. The disulfide bonds in HPV16 is between <scene name='74/746002/L1_cys_175new/1'>Cys175</scene> and Cys428, which cannot be modeled due to being located in a disordered region<ref name="mcp"/>. L1 Major Capsid Protein is associated with L2 Minor Capsid Protein. The L1 Major Capsid Protein is built of mainly <scene name='74/746002/L1_beta_sheets/1'>Beta sheets</scene> <ref> http://www.uniprot.org/uniprot/P03101 </ref> shown in orange. Other inactive ingredients in Gardasil 9 are amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water <ref>https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf</ref>. Amorphous aluminum hydroxyphosphate sulfate is used to increase the antibody response in the body by increasing the ability of the antigen to have a response to the virus <ref>PMID:17581283</ref>. Yeast is used to express the specific protein from each HPV virus type in order to create numerous copies of those proteins <ref>http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm</ref>. L-histidine is an enzymes used to create histamines that creates an immuno-response against a pathogen <ref>http://www.news-medical.net/health/Histamine-Storage-and-Release.aspx</ref>. Polysorbate 80 is used is vaccines in order to create an even blend of all the ingredients in the vaccine <ref>www.westonaprice.org/health-topics/vaccination/adjuvants-in-vaccines/</ref>. Sodium borate and water are used as a buffer and a solvent, respectively, for the other ingredients ingredients in Gardasil <ref>http://www.immune.org.nz/sites/default/files/resources/ConcernVaccineIngredients20140522V01Final.pdf</ref>. |
== Relevance to Human Health and Disease == | == Relevance to Human Health and Disease == | ||
- | Human Papillomavirus (HPV) has over 100 known strains that have been classified into 16 different groups (A-P), and it can be distinguished into two infectious groups: cutaneous HPV and mucosal HPV. Infection of HPV causes papillomas on the site of infection, which can include (but not limited to) the anus, vulva, scrotum, penis, and groin. The human papilloma virus is one of the most common sexually transmitted diseases in the world <ref name="Murray">Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. "Papillomavirus and Polyomavirus." Medical Microbiology. Philadelphia: Elsevier/Saunders, 2013. 445-450.</ref>. | + | Human Papillomavirus (HPV) has over 100 known strains that have been classified into 16 different groups (A-P), and it can be distinguished into two infectious groups: cutaneous HPV and mucosal HPV. Infection of HPV causes papillomas on the site of infection, which can include (but not limited to) the anus, vulva, scrotum, penis, and groin. The human papilloma virus is one of the most common sexually transmitted diseases in the world <ref name="Murray">Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. "Papillomavirus and Polyomavirus." Medical Microbiology. Philadelphia: Elsevier/Saunders, 2013. 445-450.</ref>. In the United States alone, HPV accounts 26,900 new cases of cancer and 6130 deaths each year. <ref>http://www.kegel.com/hpv/deaths/</ref>. |
HPV can be transmitted on fomites, with asymptomatic shedding promoting transmission. HPV can be acquired from direct contact with small breaks in the skin or mucosa, from sexual intercourse, or when an infant passes through an infected birth canal <ref name="Murray"/>. | HPV can be transmitted on fomites, with asymptomatic shedding promoting transmission. HPV can be acquired from direct contact with small breaks in the skin or mucosa, from sexual intercourse, or when an infant passes through an infected birth canal <ref name="Murray"/>. | ||
Line 19: | Line 21: | ||
</StructureSection> | </StructureSection> | ||
+ | |||
+ | ==3D structures of major capsid protein L1== | ||
+ | |||
+ | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | |||
+ | [[3iyj]] – MCP – bovine papilloma virus 1 – Cryo EM<br /> | ||
+ | [[6l31]] – Hpv6MCP – human papilloma virus 6 – Cryo EM<br /> | ||
+ | [[2r5k]] – Hpv11MCP – human papilloma virus 11<br /> | ||
+ | [[2r5h]] – Hpv16MCP – human papilloma virus 16<br /> | ||
+ | [[3j7g]], [[3j6r]], [[5kep]], [[5keq]], [[5bsp]], [[6bt3]], [[7kzf]] – Hpv16MCP – Cryo EM<br /> | ||
+ | [[1dzl]] – Hpv16MCP (mutant) – Cryo EM<br /> | ||
+ | [[3j8v]], [[3j8w]], [[3j8z]], [[3jba]], [[6bsp]], [[7cn2]] – Hpv16MCP + antibody – Cryo EM<br /> | ||
+ | [[5w1o]] – Hpv16MCP + heparin<br /> | ||
+ | [[2r5i]] – Hpv18MCP – human papilloma virus 18<br /> | ||
+ | [[5w1x]] – Hpv18MCP (mutant) + heparin<br /> | ||
+ | [[6ige]] – Hpv33MCP (mutant) – human papilloma virus 33<br /> | ||
+ | [[2r5j]] – Hpv35MCP – human papilloma virus 35<br /> | ||
+ | [[6igf]] – Hpv52MCP – human papilloma virus 52<br /> | ||
+ | [[6igc]], [[6igd]], [[5y9e]] – Hpv58MCP – human papilloma virus 58<br /> | ||
+ | [[7dn5]] – Hpv58MCP – Cryo EM<br /> | ||
+ | [[5y9c]] – Hpv58MCP + antibody <br /> | ||
+ | [[7dnh]], [[7dnk]], [[7dnl]] – Hpv58MCP + antibody – Cryo EM<br /> | ||
+ | [[5j6r]] – Hpv59MCP (mutant) – human papilloma virus 59<br /> | ||
+ | [[5jb1]] – Hpv59MCP – Cryo EM<br /> | ||
+ | [[5y9f]] – Hpv59MCP + antibody <br /> | ||
+ | |||
== References == | == References == | ||
<references/> | <references/> |
Current revision
|
3D structures of major capsid protein L1
Updated on 24-October-2021
3iyj – MCP – bovine papilloma virus 1 – Cryo EM
6l31 – Hpv6MCP – human papilloma virus 6 – Cryo EM
2r5k – Hpv11MCP – human papilloma virus 11
2r5h – Hpv16MCP – human papilloma virus 16
3j7g, 3j6r, 5kep, 5keq, 5bsp, 6bt3, 7kzf – Hpv16MCP – Cryo EM
1dzl – Hpv16MCP (mutant) – Cryo EM
3j8v, 3j8w, 3j8z, 3jba, 6bsp, 7cn2 – Hpv16MCP + antibody – Cryo EM
5w1o – Hpv16MCP + heparin
2r5i – Hpv18MCP – human papilloma virus 18
5w1x – Hpv18MCP (mutant) + heparin
6ige – Hpv33MCP (mutant) – human papilloma virus 33
2r5j – Hpv35MCP – human papilloma virus 35
6igf – Hpv52MCP – human papilloma virus 52
6igc, 6igd, 5y9e – Hpv58MCP – human papilloma virus 58
7dn5 – Hpv58MCP – Cryo EM
5y9c – Hpv58MCP + antibody
7dnh, 7dnk, 7dnl – Hpv58MCP + antibody – Cryo EM
5j6r – Hpv59MCP (mutant) – human papilloma virus 59
5jb1 – Hpv59MCP – Cryo EM
5y9f – Hpv59MCP + antibody
References
- ↑ name="mcp>PMID:23800545
- ↑ 2.0 2.1 Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Res. 2016 Jun;130:101-9. doi: 10.1016/j.antiviral.2016.03.016. Epub, 2016 Apr 1. PMID:27040313 doi:http://dx.doi.org/10.1016/j.antiviral.2016.03.016
- ↑ https://www.gardasil9.com
- ↑ 4.0 4.1 http://www.hpvvaccine.org.au/the-hpv-vaccine/how-does-it-work.aspx
- ↑ 5.0 5.1 https://www.medicines.org.uk/emc/medicine/19016
- ↑ Harper DM, Vierthaler SL, Santee JA. Review of Gardasil. J Vaccines Vaccin. 2010 Nov 23;1(107). pii: 1000107. PMID:23805398 doi:http://dx.doi.org/10.4172/2157-7560.1000107
- ↑ http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000703/WC500021140.pdf
- ↑ Finnen RL, Erickson KD, Chen XS, Garcea RL. Interactions between papillomavirus L1 and L2 capsid proteins. J Virol. 2003 Apr;77(8):4818-26. PMID:12663788
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedmcp
- ↑ http://www.uniprot.org/uniprot/P03101
- ↑ https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
- ↑ Caulfield MJ, Shi L, Wang S, Wang B, Tobery TW, Mach H, Ahl PL, Cannon JL, Cook JC, Heinrichs JH, Sitrin RD. Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice. Hum Vaccin. 2007 Jul-Aug;3(4):139-45. Epub 2007 Apr 5. PMID:17581283
- ↑ http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm
- ↑ http://www.news-medical.net/health/Histamine-Storage-and-Release.aspx
- ↑ www.westonaprice.org/health-topics/vaccination/adjuvants-in-vaccines/
- ↑ http://www.immune.org.nz/sites/default/files/resources/ConcernVaccineIngredients20140522V01Final.pdf
- ↑ 17.0 17.1 17.2 Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. "Papillomavirus and Polyomavirus." Medical Microbiology. Philadelphia: Elsevier/Saunders, 2013. 445-450.
- ↑ http://www.kegel.com/hpv/deaths/
Proteopedia Page Contributors and Editors (what is this?)
Morgan Smith, Michal Harel, Jessica Troutman., Maximillia Jackson., Jaime Prilusky